secwatch.observer — SEC 8-K summary
======================================

Issuer:     Deciphera Pharmaceuticals, Inc. (—)
CIK:        0001654151
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001193125-24-158772
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ono completes $2.4B acquisition of Deciphera; shares converted at $25.60 each
-----------------------------------------------------------------------------

- 88.3% of shares tendered; all conditions satisfied; merger effective June 11, 2024.
- Each share converted to $25.60 cash; total consideration approx. $2.4 billion.
- Deciphera becomes wholly owned subsidiary of Ono; board replaced by Toichi Takino and Masayuki Tanigawa.
- Nasdaq listing suspended; Form 15 to be filed to terminate SEC reporting obligations.
- 2024 Annual Meeting cancelled due to closing of the merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1654151/000119312524158772/0001193125-24-158772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1654151/000119312524158772/d824393d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer